» Articles » PMID: 35680004

Insight Towards the Effect of the Multi Basic Cleavage Site of SARS-CoV-2 Spike Protein on Cellular Proteases

Overview
Journal Virus Res
Specialty Microbiology
Date 2022 Jun 9
PMID 35680004
Authors
Affiliations
Soon will be listed here.
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection presents an immense global health problem. Spike (S) protein of coronavirus is the primary determinant of its entry into the host as it consists of both receptor binding and fusion domain. Besides tissue tropism, and host range, coronavirus pathogenesis are primarily controlled by the interaction of S protein with the cell receptor. Moreover, the proteolytic activation of S protein by host cell proteases plays a decisive role. The host-cell proteases have shown to be involved in the proteolysis of S protein and cleaving it into two functional subunits, S1 and S2, during the maturation process. In the present study, the interaction of the S protein of SARS-CoV-2 with different host proteases like furin, cathepsin B, and plasmin has been analyzed using molecular docking and molecular dynamics (MD) simulation. Incorporation of the furin cleavage site (R-R-A-R) in the S protein of SARS-CoV-2 has been studied by mutating the individual amino acid. MD simulation results suggest the polytropic nature of the S protein. Our analysis indicated that a single amino acid substitution in the polybasic cleavage site of S protein perturb the binding of cellular proteases. This mutation study might help to generate an attenuated SARS-CoV-2. Besides, targeting host proteases by inhibitors may result in a practical approach to stop the cellular spread of SARS-CoV-2 and develop its antiviral.

Citing Articles

Structure-based virtual screening methods for the identification of novel phytochemical inhibitors targeting furin protease for the management of COVID-19.

Tiwari P, Chouhan M, Mishra R, Gupta S, Chaudhary A, Al-Zharani M Front Cell Infect Microbiol. 2024; 14:1391288.

PMID: 38919703 PMC: 11196402. DOI: 10.3389/fcimb.2024.1391288.


Fibrinolytic system and COVID-19: From an innovative view of epithelial ion transport.

Fu Y, Xue H, Wang T, Ding Y, Cui Y, Nie H Biomed Pharmacother. 2023; 163:114863.

PMID: 37172333 PMC: 10169260. DOI: 10.1016/j.biopha.2023.114863.


Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19.

Shmakova A, Popov V, Romanov I, Khabibullin N, Sabitova N, Karpukhina A Int J Mol Sci. 2023; 24(2).

PMID: 36674896 PMC: 9867169. DOI: 10.3390/ijms24021382.


The Association of Genotype and Soluble suPAR Serum Level with COVID-19-Related Lung Damage Severity.

Nekrasova L, Shmakova A, Samokhodskaya L, Kirillova K, Stoyanova S, Mershina E Int J Mol Sci. 2022; 23(24).

PMID: 36555850 PMC: 9785175. DOI: 10.3390/ijms232416210.


Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19.

Dankwa B, Broni E, Enninful K, Kwofie S, Wilson M Struct Chem. 2022; 33(6):2221-2241.

PMID: 36118173 PMC: 9470509. DOI: 10.1007/s11224-022-02056-1.


References
1.
Alexander D, Brown I . History of highly pathogenic avian influenza. Rev Sci Tech. 2009; 28(1):19-38. DOI: 10.20506/rst.28.1.1856. View

2.
Murakami M, Towatari T, Ohuchi M, Shiota M, Akao M, Okumura Y . Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus. Eur J Biochem. 2001; 268(10):2847-55. DOI: 10.1046/j.1432-1327.2001.02166.x. View

3.
Kozakov D, Beglov D, Bohnuud T, Mottarella S, Xia B, Hall D . How good is automated protein docking?. Proteins. 2013; 81(12):2159-66. PMC: 3934018. DOI: 10.1002/prot.24403. View

4.
Mohamed M, Kumar S, Paldurai A, Samal S . Sequence analysis of fusion protein gene of Newcastle disease virus isolated from outbreaks in Egypt during 2006. Virol J. 2011; 8:237. PMC: 3114776. DOI: 10.1186/1743-422X-8-237. View

5.
White J, Delos S, Brecher M, Schornberg K . Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol. 2008; 43(3):189-219. PMC: 2649671. DOI: 10.1080/10409230802058320. View